Category Archives:

By Holger Hansen BERLIN (Reuters) -German Chancellor Olaf Scholz set out a 200 billion euro ($194 billion) "defensive shield" on Thursday to protect companies and consumers against the impact of soari...

By Julie Gordon OTTAWA (Reuters) - Canadian economic activity edged up a surprise 0.1% in July, driven by strong oil sand production, while gross domestic product was most likely flat in August, Stati...

(Reuters) - Peloton Interactive Inc said on Thursday it will start selling its bikes, treadmills and other products in Dick's Sporting Goods Inc stores, as the exercise bike maker looks to expand its ...

NEW YORK (Reuters) - An estimated 239,000 homes and businesses were still without power in Puerto Rico on Thursday almost two weeks after Hurricane Fiona hit the island, data showed. After causing dev...

By Alexander Marrow MOSCOW (Reuters) - The Russian rouble surged to a more than two-month high against the dollar on Thursday, while geopolitical headwinds halted a tentative recovery on stock markets...

WASHINGTON (Reuters) - The number of Americans filing new claims for unemployment benefits unexpectedly fell last week as the labor market remains resilient despite rising headwinds from the Federal R...

BENGALURU (Reuters) -Indian bikemaker Hero MotoCorp said on Thursday it will invest $60 million in California-based Zero Motorcycles to jointly develop electric motorcycles, as it seeks to expand pres...

By Lucia Mutikani WASHINGTON (Reuters) - The U.S. economy's recovery from the COVID-19 pandemic was much stronger than initially thought amid massive fiscal stimulus, according to revisions on Thursda...

BERLIN (Reuters) - German consumer prices, harmonised to compare with other European countries, were up 10.9% on the year and rose by 2.2% month-on-month in September, preliminary data from the Federa...

(Reuters) -Biohaven Pharmaceutical Holding Company Ltd said on Thursday its experimental drug to treat amyotrophic lateral sclerosis (ALS) failed a clinical study, the second therapy by the drugmaker ...